期刊文献+

白藜芦醇经蛋白激酶G影响豚鼠心室肌细胞L-型钙通道 被引量:5

Effects of resveratrol on the L-type calcium current by protein kinase G pathway in isolated guinea pig ventricular myocytes
暂未订购
导出
摘要 目的:研究白藜芦醇经蛋白激酶G对正常豚鼠心室肌细胞L-型钙电流(ICa-L)的影响。方法:采用全细胞膜片钳技术,记录给予白藜芦醇前后ICa-L的变化,并分别记录给予蛋白激酶G(PKG)特异性激动剂8B r-cGMP(100μmol.L-1)、PKG特异性拮抗剂H8(5μmol.L-1)后白藜芦醇对ICa-L的影响。结果:(1)白藜芦醇呈浓度依赖性抑制ICa-L,1、50、100μmol.L-1可使ICa-L峰值分别低18.31%±0.68%,56.20%±2.19%,84.51%±2.52%(n=5,P<0.05),但对ICa-L激活电位、峰电位、反转电位均没有影响;(2)100μmol.L-18B r-cGMP轻度抑制ICa-L,电流密度低10.50%±1.11%,100μmol.L-18B r-cGMP+50μmol.L-1白藜芦醇使ICa-L电流密度降低87.58%±3.49%(n=6,P<0.05);(3)5μmol.L-1H8对ICa-L无影响,5μmol.L-1H8+50μmol.L-1白藜芦醇对ICa-L无抑制作用。结论:白藜芦醇浓度依赖性抑制豚鼠心室肌细胞ICa-L,此作用机制可能与PKG激活有关。 AIM: To investigate the effects of resveratrol on the L - type calcium current in isolated guinea pig ventricular myocytes. METHODS: The whole cell patch clamp method was used. RESULTS: (1) Resveratrol (1, 50, 100 μmol/L) reduced the ICa-L by 18.31%±3.15%, 56.20%±2.50% and 84.51%±4.01% in a concentration - dependent manner ( n = 5, P 〈 0. 05 ). But it has no change on I - V shape of ICa-L. (2) 8Br - cGMP (100 μmol/L), an activator of protein kinase G(PKG), deduced the density of ICa-L by 10.50%±1.11%. Applying resveratrol and 8Br - cGMP simultaneously decreased the ICa-L significantly by 87. 58% ± 3.49% ( n = 6, P 〈 0. 05 ). ( 3 ) 5 μmol/L H8, a PKG inhibitor, inhibited the decrease in ICa-L caused by resveratrol. CONCLUSION: Resveratrol inhibits ICa-L in guinea pig ventricular myocytes, and this inhibitory effect involves the PKG pathway.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2007年第4期648-651,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30670216)
关键词 白藜芦醇 钙通道 蛋白激酶G 心肌细胞 Resveratrol Calcium channels Protein kinase G Cardiomyocytes
  • 相关文献

参考文献9

  • 1Jeandet P,Bessis R,Gautheron B.The production of resveratrol by grape berriesin different developmental stages[J].Am J Enol Vitic,1991,42(2):41-46.
  • 2刘兆平,霍军生.白藜芦醇的生物学作用[J].国外医学(卫生学分册),2002,29(3):146-148. 被引量:48
  • 3Kazuto Y,Muneshige K,Masahiro A,et al.An improved method for isolating cardiac myocytes useful for patch clamp studies[J].Jpn J Physiol,1990,40(1):157-163.
  • 4Bradamante S,Barenghi L,Piccinini F,et al.Resveratrol provides late-phase cardioprotection by means of a nitric oxide-and adenosine-mediated mechanism[J].Eur J Pharmacol,2003,465(1-2):115-123.
  • 5Hattori R,Otani H,Maulik N,et al.Pharmacological preconditioning with resveratrol:role of nitricoxide[J].Am J Physiol,2002,282(6):H1988-H1995.
  • 6Hung LM,Su MJ,Chu WK.et al.The protective effect of resveratrols on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy[J].Br J Pharmacol,2002,135(7):1627-1633.
  • 7Imamura G,Bertelli AA,Bertlli A,et al.Pharmacological preconditioning with resveratrol:an insight with iNOS knockout mice[J].Am J Physiol,2002,282(6):H1996-H2003.
  • 8Hartzell HC,Fischmeister R.Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells[J].Nature,1986,323(6085):273-275.
  • 9Cuppoletti J,Thakkar J,Sperelakis N,et al.Cardiac sarcolemmal substrate of the cGMP-dependent protein kinase[J].Membr Biochem,1989,7(3):135-142.

共引文献47

同被引文献44

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部